Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is a once-weekly injection given under the skin using a pre-filled KwikPen. Each pen contains four doses. You inject on the same day each week, rotating between three sites: the abdomen, thigh, or upper arm. These are prescription-only medicines, so the directions your prescriber and the Patient Information Leaflet provide take priority over anything you read online. The notes below explain the process clearly so you arrive at your first injection feeling prepared, not anxious.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Take your Mounjaro KwikPen from the fridge and set it on a clean surface. Let it sit at room temperature for a few minutes; injecting a cold liquid is more likely to sting. While you wait, wash your hands thoroughly with soap and water.
Now do a 30-second check you can build into a habit: hold the pen up to a light source and look through the viewing window. The liquid should be clear and colourless to pale yellow. If it looks cloudy, discoloured, or contains visible particles, do not use it. Pick a fresh needle from your pack, attach it firmly, and remove both caps. You do not need to prime the pen, the KwikPen is ready to use once the needle is attached and capped.
It is worth reading the full Mounjaro instructions page before your very first injection; it covers the pen mechanics in detail. The Patient Information Leaflet inside the carton is the legally approved reference and should always be your first stop for anything the leaflet covers, storage windows, disposal, what to do if a dose is missed.
For further reading on tirzepatide's clinical profile, the NHS tirzepatide medicines page is a reliable starting point.
The three approved injection sites are the abdomen (at least 5 cm away from the navel), the front of the outer thigh, and the upper arm. Rotating between them week to week (and moving the exact spot within a site) keeps the skin healthy and maintains consistent absorption.
Pinch a small fold of skin, hold the pen flat against it at a 90-degree angle, and press the plunger firmly until you hear a click. Keep the pen pressed in place for a few seconds after the click so the full dose is delivered, then remove the pen. You do not need to rub the site afterwards.
Never inject into skin that is bruised, scarred, irritated, or has been used for a recent injection. If you are also taking insulin, use a different site for each. Discard the used needle immediately into a sharps container, never into household waste. Interactions with other medicines are worth discussing with your prescriber before you start, particularly if your medication schedule involves oral drugs taken at specific times.
Pick a day of the week that fits your routine and stick with it. Some people find anchoring it to a regular event (a weekly call, a gym session) stops it sliding. If your schedule shifts, you may take the dose up to three days early or late without resetting your weekly pattern, provided the doses are at least four days apart; the Patient Information Leaflet gives the exact wording. If the window has passed, skip that dose and continue from your next scheduled day. Never take two doses to make up for one missed.
Questions about dose increases, how long to stay at each strength, or what happens if you need to pause treatment are clinical decisions. They belong in a conversation with a prescriber, not on a forum. If you are exploring what Mounjaro costs on a private prescription or want to understand the wider landscape before starting, our treatment page has a clear overview.
A broad overview of the Mounjaro treatment as a whole (including how tirzepatide works as a dual GIP and GLP-1 receptor agonist) is on the Mounjaro page. If you want to understand the mechanism in more clinical depth, the tirzepatide overview goes further.
The most common effects when starting or moving up a dose are gastrointestinal: nausea, loose stools, constipation, reflux or burping. They tend to be at their worst in the first few days after an injection and ease as your body adjusts to each new dose level. Eating smaller portions, staying well hydrated and avoiding very rich or fatty meals around injection day all help.
A few effects need prompt medical attention rather than watchful waiting. Severe abdominal pain that spreads to the back (with or without vomiting) warrants a call to 111 or a trip to A&E; the MHRA highlighted acute pancreatitis as a known, infrequent but serious risk in a Drug Safety Update issued in January 2026. Symptoms of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing) need immediate emergency help. If you notice anything unexpected and are unsure whether it is linked to treatment, your prescriber is the right person to contact first.
Some readers ask whether Mounjaro is connected to other unexpected symptoms, there is a separate page on Mounjaro and urine infections and one on yeast infections and Mounjaro if those questions come up. Suspected side effects can also be reported directly via the MHRA Yellow Card scheme.
If you would like a prescriber to review whether Mounjaro is suitable for you, start your free consultation, a GPhC-registered prescriber reads every submission the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.